Tenapanor

Last Updated: 04/28/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 158 publications

Role of Na+/H+ exchanger 3 in acidification and morphological remodeling of tubulovesicles in gastric parietal cells.

Role of Na+/H+ exchanger 3 in acidification and morphological remodeling of tubulovesicles in gastric parietal cells.

Journal: American journal of physiology. Cell physiology

Published: April 10, 2026

Reduction in Gastrointestinal Visits and Portal Messaging Following Tenapanor Initiation in Patients in Community Gastrointestinal Practices.

Reduction in Gastrointestinal Visits and Portal Messaging Following Tenapanor Initiation in Patients in Community Gastrointestinal Practices.

Journal: Gastroenterology & hepatology

Published: February 02, 2026

Treatment Satisfaction With Tenapanor: Real-World Survey of Patients With IBS-C.

Treatment Satisfaction With Tenapanor: Real-World Survey of Patients With IBS-C.

Journal: Gastroenterology & hepatology

Published: February 02, 2026

Tenapanor Improves Abdominal Bloating Symptoms in Patients With IBS-C Experiencing Moderate-to-Severe Bloating.

Tenapanor Improves Abdominal Bloating Symptoms in Patients With IBS-C Experiencing Moderate-to-Severe Bloating.

Journal: Gastroenterology & hepatology

Published: February 02, 2026

Efficacy and Safety of Tenapanor in IBS-C: A Systematic Review and Meta-Analysis.

Efficacy and Safety of Tenapanor in IBS-C: A Systematic Review and Meta-Analysis.

Journal: Gastroenterology & hepatology

Published: February 02, 2026

Real-World Safety Analysis of the Constipation-Predominant IBS Treatment Options Linaclotide, Lubiprostone, Plecanatide, and Tenapanor.

Real-World Safety Analysis of the Constipation-Predominant IBS Treatment Options Linaclotide, Lubiprostone, Plecanatide, and Tenapanor.

Journal: Gastroenterology & hepatology

Published: February 02, 2026

A Novel Use of Tenapanor in Patients With Hepatic Encephalopathy: A Case Series.

A Novel Use of Tenapanor in Patients With Hepatic Encephalopathy: A Case Series.

Journal: ACG case reports journal

Published: January 23, 2026

Mechanism of reduced intestinal phosphate absorption by tenapanor: a hypothesis.

Mechanism of reduced intestinal phosphate absorption by tenapanor: a hypothesis.

Journal: Clinical kidney journal

Published: October 17, 2025

Pharmacotherapy for Chronic Idiopathic Constipation and Constipation-Predominant Irritable Bowel Syndrome Beyond Conventional Laxatives: A Narrative Review.

Pharmacotherapy for Chronic Idiopathic Constipation and Constipation-Predominant Irritable Bowel Syndrome Beyond Conventional Laxatives: A Narrative Review.

Journal: Cureus

Published: October 03, 2025

Laxative logic: when lifestyle is not enough.

Laxative logic: when lifestyle is not enough.

Journal: Current opinion in gastroenterology

Published: September 29, 2025

Tenapanor for Irritable Bowel Syndrome With Constipation (IBS-C): A Systematic Review of Randomized Trials Assessing Food and Drug Administration (FDA) Composite Response, Durability, and Risk-of-Bias (RoB-2).

Tenapanor for Irritable Bowel Syndrome With Constipation (IBS-C): A Systematic Review of Randomized Trials Assessing Food and Drug Administration (FDA) Composite Response, Durability, and Risk-of-Bias (RoB-2).

Journal: Cureus

Published: September 27, 2025

Patient-Provider Conversation About IBS-C Treatment With Tenapanor.

Patient-Provider Conversation About IBS-C Treatment With Tenapanor.

Journal: Gastroenterology & hepatology

Published: September 02, 2025

Showing 1-12 of 158

Last Updated: 04/28/2026